Close

Pharmacyclics, Inc. (PCYC) Tops Q1 EPS by 39c

November 5, 2012 6:38 AM EST
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q1 EPS of $1.14, $0.39 better than the analyst estimate of $0.75. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $87.64 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings